TEVA insider buying & filings

TEVATEVA PHARMACEUTICAL INDUSTRIES LTD

NYSE · Healthcare · $44.94B

$38.53

-1.83% today

6 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Aug 25 · scanned 3m ago

Price · 1Y · daily● 5 sells

▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$44.94B

Float

1088.7M

93% public

Short % float

Pro

Price / profit

64.2

Price / future profit

12.5

Price / sales

2.6

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Aug 25SELLWeiss AmirChief Accounting Officerdirect2,500 @ $37.63$94.1K

Aug 25EXERCISEWeiss AmirChief Accounting Officerdirect2,500 @ $19.61$49.0K

Aug 25SELLWeiss AmirChief Accounting Officerdirect6,945 @ $37.61$261.2K

Aug 25SELLSatchi-Fainaro RonitDirectordirect415 @ $37.25$15.5K

Aug 19SELLLippman Evan10b5-1EVP, Business Developmentdirect18,600 @ $36.57$680.3K

Context

Wall St

$42.45 avg target

+10.2% vs today · 11 analysts · consensus Strong Buy

▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice

Coverage

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice